Aurigene Discovery Technologies Limited - Product Pipeline Review - 2014

Published: Jul, 2014 | Pages: 38 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Aurigene Discovery Technologies Limited - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Aurigene Discovery Technologies Limited - Product Pipeline Review - 2014', provides an overview of the Aurigene Discovery Technologies Limited's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Aurigene Discovery Technologies Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Aurigene Discovery Technologies Limited including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Aurigene Discovery Technologies Limited's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Aurigene Discovery Technologies Limited's pipeline products

Reasons to buy

- Evaluate Aurigene Discovery Technologies Limited's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Aurigene Discovery Technologies Limited in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Aurigene Discovery Technologies Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Aurigene Discovery Technologies Limited and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Aurigene Discovery Technologies Limited
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Aurigene Discovery Technologies Limited and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Aurigene Discovery Technologies Limited Snapshot 5
Aurigene Discovery Technologies Limited Overview 5
Key Information 5
Key Facts 5
Aurigene Discovery Technologies Limited - Research and Development Overview 6
Key Therapeutic Areas 6
Aurigene Discovery Technologies Limited - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Partnered Products 11
Partnered Products/Combination Treatment Modalities 12
Pipeline Products - Out-Licensed Products 13
Out-Licensed Products/Combination Treatment Modalities 14
Aurigene Discovery Technologies Limited - Pipeline Products Glance 15
Aurigene Discovery Technologies Limited - Early Stage Pipeline Products 15
Preclinical Products/Combination Treatment Modalities 15
Discovery Products/Combination Treatment Modalities 16
Aurigene Discovery Technologies Limited - Drug Profiles 17
AUR-012 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Drug to Inhibit Bruton's Tyrosine Kinase for Inflammation 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Small Molecule to Agonize for ROR-Gamma for Inflammation 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Small Molecule to Inhibit DHODH for Oncology and Inflammation 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Small Molecule to Inhibit FabI for Bacterial Infections 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Small Molecule to Inhibit NAMPT for Pancreatic Cancer 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
AU-2439 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Immune Check-Point Pathway Program 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Small Molecule to Inhibit EZH2 for Oncology 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Small Molecule to Inhibit IRAK4 for Oncology 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Small Molecule to Inhibit Matriptase for Infectious Diseases and Osteoarthritis 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Aurigene Discovery Technologies Limited - Pipeline Analysis 28
Aurigene Discovery Technologies Limited - Pipeline Products by Target 28
Aurigene Discovery Technologies Limited - Pipeline Products by Route of Administration 30
Aurigene Discovery Technologies Limited - Pipeline Products by Molecule Type 31
Aurigene Discovery Technologies Limited - Pipeline Products by Mechanism of Action 32
Aurigene Discovery Technologies Limited - Recent Pipeline Updates 34
Aurigene Discovery Technologies Limited - Dormant Projects 35
Aurigene Discovery Technologies Limited - Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Appendix 37
Methodology 37
Coverage 37
Secondary Research 37
Primary Research 37
Expert Panel Validation 37
Contact Us 38
Disclaimer 38

List of Tables
Aurigene Discovery Technologies Limited, Key Information 5
Aurigene Discovery Technologies Limited, Key Facts 5
Aurigene Discovery Technologies Limited - Pipeline by Indication, 2014 8
Aurigene Discovery Technologies Limited - Pipeline by Stage of Development, 2014 9
Aurigene Discovery Technologies Limited - Monotherapy Products in Pipeline, 2014 10
Aurigene Discovery Technologies Limited - Partnered Products in Pipeline, 2014 11
Aurigene Discovery Technologies Limited - Partnered Products/ Combination Treatment Modalities, 2014 12
Aurigene Discovery Technologies Limited - Out-Licensed Products in Pipeline, 2014 13
Aurigene Discovery Technologies Limited - Out-Licensed Products/ Combination Treatment Modalities, 2014 14
Aurigene Discovery Technologies Limited - Preclinical, 2014 15
Aurigene Discovery Technologies Limited - Discovery, 2014 16
Aurigene Discovery Technologies Limited - Pipeline by Target, 2014 29
Aurigene Discovery Technologies Limited - Pipeline by Route of Administration, 2014 30
Aurigene Discovery Technologies Limited - Pipeline by Molecule Type, 2014 31
Aurigene Discovery Technologies Limited - Pipeline Products by Mechanism of Action, 2014 33
Aurigene Discovery Technologies Limited - Recent Pipeline Updates, 2014 34
Aurigene Discovery Technologies Limited - Dormant Developmental Projects,2014 35
Aurigene Discovery Technologies Limited, Other Locations 36
Aurigene Discovery Technologies Limited, Subsidiaries 36